John Kenneth Jenkins, Director at Corbus Pharmaceuticals Holdings, Inc. (CRBP), bought 1,000 shares at $6.98 ($7K) on 2019-03-15, disclosed to the SEC on 2019-03-15.
Open-market purchase of $7k CRBP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |